![Todd Branning](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Todd Branning
Director Ejecutivo en NEUBASE THERAPEUTICS, INC. .
Cargos activos de Todd Branning
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 10/01/2022 | - |
Director Ejecutivo | 16/01/2024 | - | |
Director Financiero/CFO | 10/01/2022 | - | |
Secretario Corporativo | 10/01/2022 | - | |
Amneal Pharma UK Holdings Ltd.
![]() Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | Director/Miembro de la Junta | 17/04/2019 | - |
Amneal UK Holding Co. Ltd.
![]() Amneal UK Holding Co. Ltd. Financial ConglomeratesFinance Part of Amneal Pharmaceuticals, Inc., Amneal UK Holding Co. Ltd. is a company that functions as an investment holding company. Amneal UK Holding Co. Ltd. is based in London, UK. Founded in 2017. | Director/Miembro de la Junta | 17/04/2019 | - |
Historial de carrera de Todd Branning
Antiguos cargos conocidos de Todd Branning.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Director Financiero/CFO | 13/07/2020 | 04/06/2021 |
Contacto de Relaciones con Inversores | 13/07/2020 | 04/06/2021 | |
Treasurer | 13/07/2020 | 04/06/2021 | |
Amneal Intermediate, Inc.
![]() Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Director Financiero/CFO | 22/01/2019 | 11/03/2020 |
Contacto de Relaciones con Inversores | 22/01/2019 | 11/03/2020 | |
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Director Financiero/CFO | 01/01/2016 | 01/01/2018 |
Corporate Officer/Principal | 01/01/2016 | 01/01/2018 | |
ALLERGAN PLC | Corporate Officer/Principal | 01/06/2013 | 01/08/2016 |
Formación de Todd Branning.
Carnegie Mellon University | Masters Business Admin |
University of Miami | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 3 |
Irlanda | 2 |
Operativa
Director of Finance/CFO | 4 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Teva Pharmaceuticals USA, Inc.
![]() Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Amneal Intermediate, Inc.
![]() Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
Amneal Pharma UK Holdings Ltd.
![]() Amneal Pharma UK Holdings Ltd. Medical DistributorsDistribution Services Part of Amneal Pharmaceuticals, Inc., Amneal Pharma UK Holdings Ltd. is a company that sells pharmaceutical products. Amneal Pharma UK Holdings Ltd. is based in Felsted, UK. Founded in 2013. | Distribution Services |
Amneal UK Holding Co. Ltd.
![]() Amneal UK Holding Co. Ltd. Financial ConglomeratesFinance Part of Amneal Pharmaceuticals, Inc., Amneal UK Holding Co. Ltd. is a company that functions as an investment holding company. Amneal UK Holding Co. Ltd. is based in London, UK. Founded in 2017. | Finance |
NeuBase Therapeutics, Inc.
![]() NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on March 29, 2002 and is headquartered in Pittsburgh, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Todd Branning
- Experiencia